Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection
Similar Posts
NAACOS and Innovaccer: Health Care Leaders Rethink Tech for CMS’ ACCESS Model
Survey finds funding is the biggest barrier to adopting technology-enabled care The National Association of ACOs (NAACOS) and Innovaccer…
Intelligent Mattress Developed in Germany for the Prevention of Pressure Sores
Some 400,000 people in Germany each year suffer from painful pressure sores on the skin, known as decubitus ulcers….
Current Health Chosen to Power South Shore Health’s Post-Acute Care Program
Current Health’s remote healthcare platform enables continuous monitoring of high-risk patients while reducing resource strain Current Health announced…
